State Street’s Indaptus Therapeutics INDP Stock Holding History

State Street’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-467	Closed	-$7.19K	–	4294
2025 Q1	$7.19K	Hold	467	–	–	﹤0.01%	4263
2024 Q4	$11K	Hold	467	–	–	﹤0.01%	4274
2024 Q3	$16.2K	Hold	467	–	–	﹤0.01%	4238
2024 Q2	$27.7K	Hold	467	–	–	﹤0.01%	4237
2024 Q1	$29.3K	Sell	467 -228	-33%	-$12.1K	﹤0.01%	4246
2023 Q4	$34.5K	Hold	695	–	–	﹤0.01%	4263
2023 Q3	$53K	Hold	695	–	–	﹤0.01%	4277
2023 Q2	$35.6K	Hold	695	–	–	﹤0.01%	4499
2023 Q1	$36K	Hold	695	–	–	﹤0.01%	4582
2022 Q4	$28K	Hold	695	–	–	﹤0.01%	4677
2022 Q3	$42K	Hold	695	–	–	﹤0.01%	4688
2022 Q2	$51K	Hold	695	–	–	﹤0.01%	4716
2022 Q1	$78K	Buy	+695	New	+$89.2K	﹤0.01%	4706

Other funds holding INDP

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street's INDP Position: Q2 2025 in Review

State Street sold out of Indaptus Therapeutics (INDP) in Q2 2025, closing a stake of 467 shares — an estimated $7.19K sold.

State Street first reported a position in INDP in Q1 2022 and held it in 13 quarters. The position peaked at $78K in Q1 2022. 5 funds tracked by Wall St. Rank hold INDP as of Q2 2025.

State Street reported no remaining Indaptus Therapeutics position as of Q2 2025 after selling out during the quarter.
State Street sold 467 Indaptus Therapeutics shares in Q2 2025, an estimated $7.19K.
State Street first reported a position in Indaptus Therapeutics in Q1 2022 and held it in 13 quarters.
State Street's Indaptus Therapeutics position peaked at $78K in Q1 2022.
5 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2025.

Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.